HK2 and colorectal carcinoma: Among all, HKII is frequently upregulated in multiple cancers, including breast (Sato-Tadano et al., 2013), glioblastoma (Wolf et al., 2011), prostate (Lee et al., 2019), and CRC (Ho and Coomber, 2016).